You just read:

ONCOTHYREON ANNOUNCES PUBLICATION OF SAFETY & SURVIVAL DATA FROM STIMUVAX PHASE 1/2 NON-SMALL CELL LUNG CANCER TRIAL

News provided by

Oncothyreon Inc.

Oct 07, 2010, 08:00 ET